Mexiletine
Back to searchMolecule Structure
Scientific Name
Mexiletine
Description of the Drug
Mexiletine is a class 1B antiarrhythmic agent used in the treatment of documented ventricular arrhythmias that warrant treatment.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00379
http://www.drugbank.ca/drugs/DB00379
Brand Name(s)
Not Available
Company Owner(s)
Zenara Pharma Private Ltd, Teva Pharmaceuticals Usa Inc, Senores Pharmaceuticals Inc, Crossmedika Sa, Watson Laboratories Inc, Novast Laboratories Ltd, Boehringer Ingelheim, Ani Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
Atlas | mexiletine | |
SureChEMBL | SCHEMBL16081 | |
PharmGKB | PA450488 | |
Human Metabolome Database | HMDB0014523 | |
DrugBank | DB00379 | |
PubChem: Thomson Pharma | 14772717 | |
PubChem | 4178 | |
Mcule | MCULE-1930292316 | |
LINCS | LSM-1700 | |
Nikkaji | J19.958C | |
BindingDB | 50117271 | |
EPA CompTox Dashboard | DTXSID8048446 | |
DrugCentral | 1794 | |
Brenda | 122768 | |
ChemicalBook | CB9497353 | CB22750077 |
Guide to Pharmacology | 2629 | |
rxnorm | MEXILETINE HYDROCHLORIDE | MEXILETINE |
KEGG Ligand | C07220 | |
ChEBI | 6916 |